Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: A literature review

Abdominal Imaging

Volumn 33, Issue 2, 2008, Pages 183-190

  Wong, Wai Lup ^a   Chambers, R Jane ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Gastro oesophageal cancer; PET CT, FDG; Restaging; Staging; Thoracic oesophageal cancer

Indexed keywords

FLUORODEOXYGLUCOSE; TRACER;

ARTICLE; CANCER STAGING; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HISTOPATHOLOGY; HUMAN; METASTASIS; OCCULT CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; ESOPHAGUS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41949086727     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-007-9241-1     Document Type: Article

References (61)

1. Lerut T, Decker G (1999) Oesophageal cancer Curr Opin Gastroenterol 15:364-369
2. Muller JM, Erasmi H, Stelzner M, Zieran U, Pichlman H (1990) Surgical therapy of oesophageal cancer Br J Surg 77:845-857
3. Geh JI, Crellin AM, Glynn Jones R (2001) Pre-operative (neo-adjuvant) chemotherapy in oesophageal cancer Br J Surg 88:338-356
4. Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL (2005) Health related quality of life during neoadjuvant treatment and surgery for localised oesophageal carcinoma Cancer 103:1791-1799
5. Rice TW (2000) Clinical staging of oesophageal cancer CT EUS and PET, Chest Surgery Clin N Am 10:471-485
6. Czernin J, Phelps ME (2002) Positron emission tomography scanning: current and future applications Ann Rev Med 53:89-112
7. A framework for the development of PET services in England. Department of Health document October 2005 gateway number 5265
8. Block MI, et al. (1997) Improvement in staging of esophageal cancer with the addition of Positron Emission Tomography, Ann Thorac Surg 64:770-777
9. Flamen P, et al. (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol 18:3202-3210
10. Kato, et al. (2002) Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 4:921-928
11. Kim, et al. (2001) Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography Ann Thorac Surg 71:290-294
12. Kole AC, et al. (1988) Positron emission tomography for staging of oesophageal and gastroesophageal malignancy Br J Cancer 78: 521-527
13. Rankin SC, et al. (1988) Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma Clin Radiol 53: 659-665
14. 18 F-FDG positron emission tomography gastric and oesophageal carcinoma BJR 72:525-529
15. Neto C, Zhuang H, Ghesani N, Alavi A (2001) Detection of Barretts oeophagus superimposed by oesophageal cancer by FDG positron emission tomography Clin Nucl Med 26:1060
16. Bakheet S, Amin T, Alia A-G, Kuzo R, Powe J (1999) f-18 FDG uptake in benign oesophageal cancer Clin Nucl Med 24:995
17. 18 F-fluorodeoxyglucose positron emission tomography AJR 168:417-424
18. 18 F-FDG PET JNM 45:980-987
19. Lerut T, et al. (2000) Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy Ann Surg 232:743-752
20. Meltzer CC, et al. (2000) Whole-body FDG positron emission tomographic imaging for staging esophageal cancer: comparison with computed tomography Clin Nucl Med 25:882-887
21. Lowe VJ, Booya F, Fletcher JG, et al. (2006) Comparision of PET, CT and EUS in the initial staging of patients with oesophageal cancer Mol Imaging Biol 7:422-430
22. Luketich JD, et al. (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans Ann Thorac Surg 68:1133-1137
23. Duong CP, et al. (2006) Significant clinical impact and prognostic stratification provided by FDG PET in the staging of oesophageal cancer Eur J Nucl Med Mol Imaging 33:759-769
24. Blackstock AW, et al. (2006) A prospective evaluation of the impact of FDG PET staging on survival for patients with locally advanced oesophageal cancer Int J Radiat Oncol Biol Phys 64:455-460
25. Hong D, et al. (2005) Value of baseline PET for predicting overall survival in patient with non-metastatic oesophageal or gastro-oesophageal junction cancer Cancer 104:1602-1606
26. Fukunaga T, et al. (1988) Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET J Nucl Med 39:1002-1007
27. Cerfolio RJ, Bryant AS (2006) Maximum standardized uptake values on positron emission tomography of oesophageal cancer predicts stage, tumour biology and survival Ann Thorac Surg 82:391-395
28. Rizk N, et al. (2006) Preoperative FDG PET SUV predict survival after oesophageal adenocarcinoma resection Ann Thorac Surg 81:1076-1082
29. Westreenen M, et al. (2005) Esophageal cancer: CT, endoscopic US and FDG PET for assessment of response to neoadjuvant therapy- systematic review Radiology 236:841-851
30. Downey RJ, et al. (2003) Whole body 18-FDG PET and the response of oesophageal cancer to induction therapy: results of a prospective study J Clin Oncol 21:428-432
31. Flamen P, et al. (2002) PET for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer Ann Oncol 13:361-368
32. Weber et al. (2001) Prediction of response to pre-operative chemotherapy in adenocarcinomas of the esophageal junction by metabolic imaging J Clin Oncol 19:3058-3065
33. Brucher BJDM, et al. (2001) Neoadjuvant therapy of oesophageal squamous cell carcinoma: response evaluation by PET Ann Surg 233:300-309
34. Couper GW, et al. (1998) Detection of response to chemotherapy using PET in patients with oesophageal and gastric cancer Br J Surg 85:1403-1406
35. Cefolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA (2005) The accuracy of EUS with FNA, integrated PET CT and CT in restaging patients with oesophageal cancer after neo-adjuvant chemotherapy J Thorac Cadiovas Surg 129:1232-1241
36. Melcher L, Wong WL, Sanghera B, et al. (2004) Sequential FDG-PET scanning in the assessment of response to neoadjuvant chemotherapy in operable esophageal cancer. J Clin Oncol 22,14S:4056
37. Melcher L, Sanghera B, Wong WL, et al (2006) The relationship between FDG PET values histological response and survival in patients undergoing neoadjuvant chemotherapy for potentially operable oesophageal cancer. J Clin Oncol 24:18S
38. Korst RJ, Kansler AL, Port JL, Lee PC, Kerem Y, Altorki NK (2006) Downstaging of T or N predicts long term survival after pre-operative chemotherapy and radical resection for oesophageal cancer Ann Thorac Surg 82:480-485
39. Duong CP, et al. (2006) FDG PET status following chemoradiation provides high management impact and powerful prognostic stratification in oesophageal cancer Eur J Nucl Med Mol Imaging 33:770-778
40. Levine EA, et al. (2006) Predictive value of FDG PET in the identification of responders to chemoradiation therapy for the treatment of locally advanced oesophageal cancer Ann Surg 243:472-478
41. Westerterp M, van Westreenen HL, Sloof GW, Plukker J, Th M, van Lanschot JJB (2006) Role of PET in the (re-) staging of oesophageal cancer Scaninavian J Gastroent 41(suppl 243):116-122
42. van Westreenen et al. (2005) Synchronous primary neoplasms detected on FDG in staging of patients with oesophageal cancers J Nucl Med 46:1321-1325
43. Assessment(2000) In: Watkinson Gaze MN, Wilson JA, (eds). Stell & Maran's Head and neck surgery, 4th edn. Butterworth Heinemann publication, Oxford, chap 2, pp 11-28
44. Wong WL, et al. (1996) Validation and clinical application of computer combined CT and PET with FDG head and neck images Am J Surg 172:628-632
45. Lardinosis D, et al. (2003) Integrated PET CT imaging improves staging of NSCLC n Eng J Med
46. Shim SS, et al. (2005) Non-small cell lung cancer prospective comparision of intergrated FDG PET CT and CT alone for pre-operative staging Radiology 1011:1019
47. Bar-Shalom R, et al. (2005) The additional valyue of PET/ CT over PET and FDG imaging of oesophageal cancer Eur J Nucl Med Mol Imaging 32:918-924
48. Rampin L, Rubello D, Nanni C, Fanti S (2005) Value of PET CT fusion imaging in avoiding potential pitfalls in the interpretation of 18-F-FDG accumulation in the distal oesophagus Eur J Nucl Med Mol Imaging 32:990-992
49. O'Doherty MJ, Barrington S (2003) PET imaging in HIV infection. In: Valk P, Bailey DL, Townsend DW, Maisey MN, (eds). PET Basic science and clinical practice. Springer, London, chap 43, pp 741-752
50. Wohrer S, et al. (2006) FDG PET visualizes follicular lymphoma irrespective of grading Ann Oncol 17:780-784
51. Hany TF (2003) PET and PET/CT of the liver and pancreas In: Von Schulthess GK, (ed). Clinical molecular imaging. Williams & Wilkins, Philadelphia, chap 46, pp 334-340
52. Strauss LG (1996) FDG and false positive results: a major problem in the diagnosis of oncology patients Eur J Nucl Med 23:1309-1414
53. Cook GJR (2003) Artifacts and normal variants in whole body PET imaging. In Valk P, Bailey DL, Townsend DW, Maisey MN, (eds). PET Basic science and clinical practice. Springer, London, chap 24, pp 495-505
54. Wong WL, Saunders M (2002) Role of FDG PET in the assessment of indeterminate pulmonary lesions Clin Oncol 14:123-128
55. Van Westreenen HL, et al. (2003) Pitfalls of positive findings in staging oesophageal cancer with FDG PET Ann Surg Oncol 10:1100-1105
56. 18 F-fluorodoexyglucose Cancer 86:638-1648
57. Jager PL, et al. (2001) Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med 28:1845-1849
58. Stein HJ, Brucher BLDM, Sendler A, Siewert JR (2001) Oesopahageal cancer: patient evaluation and pre-treatment staging Surg Oncol 10:103-111
59. Forshaw MJ, Gossage JA, Mason RC (2005) Neoadjuvant chemotherapy for oesophageal cancer: the need for accurate response prediction and evaluation Surgeon 3:6373-6382
60. Minsky BD, (2006) Primary combined modality therapy for oesophageal cancer Oncol 20:497-505
61. Vesselle et al. (2001) FLT PET imaging of non-small cell lung cancer: comparison to Ki67 proliferation index J Nucl Med 42:21